Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Human leukocyte antigen HLA-B alleles have better protective activity against HIV-1 than HLA-A alleles, possibly due to differences in HLA-restricted HIV-1-specific CD8+ cytotoxic T lymphocyte (CTL) function, but the mechanism is unknown. HIV-1 negative regulatory factor (Nef) mediates down-regulation of surface expression of class I HLA (HLA-I) and may therefore impair immune recognition by CTL. Because of sequence differences in the cytoplasmic domains, HLA-A and -B are down-regulated by Nef but HLA-C and -E are not affected. However, the latter are expressed at low levels and are not of major importance in the CTL responses to HIV-1. Here, we compared the role of the cytoplasmic domains of HLA-A and -B in Nef-mediated escape from CTL. We found HLA-B cytoplasmic domains were more resistant to Nef-mediated down-regulation than HLA-A cytoplasmic domains and demonstrated that these differences affect CTL recognition of virus-infected cells in vitro. We propose that the relative resistance to Nef-mediated down-regulation by the cytoplasmic domains of HLA-B compared with HLA-A contributes to the better control of HIV-1 infection associated with HLA-B-restricted CTLs.

Original publication

DOI

10.1073/pnas.1204199109

Type

Journal article

Journal

Proc Natl Acad Sci U S A

Publication Date

14/08/2012

Volume

109

Pages

13353 - 13358

Keywords

Alleles, Amino Acid Sequence, Cell Line, Cytoplasm, Down-Regulation, Epitopes, HIV Infections, HIV-1, HLA-A Antigens, HLA-B Antigens, HLA-B7 Antigen, HLA-C Antigens, Humans, Molecular Sequence Data, Polymorphism, Genetic, Protein Structure, Tertiary, Recombinant Proteins, Sequence Alignment, T-Lymphocytes, Cytotoxic, gag Gene Products, Human Immunodeficiency Virus, nef Gene Products, Human Immunodeficiency Virus